Does TAFAMIDIS MEGLUMINE Cause Condition aggravated? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Condition aggravated have been filed in association with TAFAMIDIS MEGLUMINE (Vyndaqel). This represents 3.3% of all adverse event reports for TAFAMIDIS MEGLUMINE.
144
Reports of Condition aggravated with TAFAMIDIS MEGLUMINE
3.3%
of all TAFAMIDIS MEGLUMINE reports
35
Deaths
69
Hospitalizations
How Dangerous Is Condition aggravated From TAFAMIDIS MEGLUMINE?
Of the 144 reports, 35 (24.3%) resulted in death, 69 (47.9%) required hospitalization, and 13 (9.0%) were considered life-threatening.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS MEGLUMINE. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does TAFAMIDIS MEGLUMINE Cause?
Death (1,196)
Cardiac failure (519)
Off label use (418)
Dyspnoea (227)
Product use in unapproved indication (202)
Cardiac failure chronic (188)
Atrial fibrillation (164)
Fatigue (163)
Disease progression (157)
Asthenia (125)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which TAFAMIDIS MEGLUMINE Alternatives Have Lower Condition aggravated Risk?
TAFAMIDIS MEGLUMINE vs TAFASITAMAB
TAFAMIDIS MEGLUMINE vs TAFASITAMAB-CXIX
TAFAMIDIS MEGLUMINE vs TAFINLAR
TAFAMIDIS MEGLUMINE vs TAFLUPROST
TAFAMIDIS MEGLUMINE vs TAGRAXOFUSP-ERZS